Page 222 - HIV/AIDS Guidelines

FTC/TDF emtricitabine + tenofovir disoproxil fumarate

GAZT azidothymidine glucuronide
GHB gamma-hydroxybutyrate
GI gastrointestinal

HAD HIV-associated dementia
HAV hepatitis A virus
HBeAg hepatitis B e antigen
HBsAg hepatitis B surface antigen
HBV hepatitis B virus

HCV hepatitis C virus
HD hemodialysis
HDL high-density lipoprotein
HELLP hemolysis, elevated liver enzymes, low platelet count (syndrome)

HHS Health and Human Services
HHV human herpes virus
HHV-8 human herpes virus-8
HIV human immunodeficiency virus
HIV-1 human immunodeficiency virus type 1
HIV-2 human immunodeficiency virus type 2

HIVAN HIV-associated nephropathy
HLA human leukocyte antigen
HPV human papilloma virus
HR hazard ratio

HRSA Health Resource Services Administration
hsCRP high sensitivity C-reactive protein
HSR hypersensitivity reaction
HTLV human T-cell leukemia virus
HTLV-1 human T-cell leukemia virus type 1
HTLV-2 human T-cell leukemia virus type 2

IAS-USA International AIDS Society-USA
IC inhibitory concentration
IDU injection drug user

IDV indinavir
IDV/r indinavir/ritonavir
IFN-γ interferon-gamma
IGRA interferon-gamma release assay

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents N-3

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.